High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke.

[1]  Xinyu Zhao,et al.  Adult neural stem cells: response to stroke injury and potential for therapeutic applications. , 2011, Current stem cell research & therapy.

[2]  T. Schormann,et al.  Mobilisation of Hematopoietic CD34+ Precursor Cells in Patients with Acute Stroke Is Safe - Results of an Open-Labeled Non Randomized Phase I/II Trial , 2011, PloS one.

[3]  M. Chopp,et al.  Multipotent Mesenchymal Stromal Cells Increase tPA Expression and Concomitantly Decrease PAI-1 Expression in Astrocytes through the Sonic Hedgehog Signaling Pathway after Stroke (in vitro Study) , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  A. Soro-Paavonen,et al.  RAGE biology, atherosclerosis and diabetes. , 2011, Clinical science.

[5]  G. Solgi,et al.  Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material , 2011, European journal of immunology.

[6]  Yu-Ching Lin,et al.  Human Umbilical Mesenchymal Stem Cells Promote Recovery After Ischemic Stroke , 2011, Stroke.

[7]  V. Pistoia,et al.  Damage‐associated molecular patterns (DAMPs) and mesenchymal stem cells: A matter of attraction and excitement , 2011, European journal of immunology.

[8]  K. Arai,et al.  Cellular Mechanisms of Neurovascular Damage and Repair After Stroke , 2011, Journal of child neurology.

[9]  Marta P Pereira,et al.  Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain , 2011, Brain : a journal of neurology.

[10]  A. Ohtsuka,et al.  Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats , 2011, Stroke.

[11]  M. Chopp,et al.  Delayed Administration of Human Umbilical Tissue-Derived Cells Improved Neurological Functional Recovery in a Rodent Model of Focal Ischemia , 2011, Stroke.

[12]  J. Kuja-Panula,et al.  High Mobility Group Box-1 (HMGB1; Amphoterin) Is Required for Zebrafish Brain Development* , 2011, The Journal of Biological Chemistry.

[13]  Q. Dong,et al.  Induction of pluripotent stem cells transplantation therapy for ischemic stroke , 2011, Molecular and Cellular Biochemistry.

[14]  L. Edvinsson,et al.  Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway , 2011, Journal of Neuroinflammation.

[15]  M. Ratajczak,et al.  Stem cells for neural regeneration--a potential application of very small embryonic-like stem cells. , 2011, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[16]  R. Zhao,et al.  Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats , 2011, Brain Research.

[17]  C. Molina.  Reperfusion Therapies for Acute Ischemic Stroke: Current Pharmacological and Mechanical Approaches , 2011, Stroke.

[18]  J. Ko,et al.  Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. , 2010, Current neurovascular research.

[19]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[20]  K. Arai,et al.  Role of ERK map kinase and CRM1 in IL‐1β‐stimulated release of HMGB1 from cortical astrocytes , 2010, Glia.

[21]  W. Young,et al.  Endothelial progenitor cell transplantation improves long‐term stroke outcome in mice , 2010, Annals of neurology.

[22]  E. Lo,et al.  Inhibition of Reactive Astrocytes with Fluorocitrate Retards Neurovascular Remodeling and Recovery after Focal Cerebral Ischemia in Mice , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  K. Abe,et al.  Tridermal Tumorigenesis of Induced Pluripotent Stem Cells Transplanted in Ischemic Brain , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  G. Ghirlanda,et al.  High-Mobility Group Box-1 Protein Promotes Angiogenesis After Peripheral Ischemia in Diabetic Mice Through a VEGF-Dependent Mechanism , 2010, Diabetes.

[25]  M. Chopp,et al.  Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse , 2010, PloS one.

[26]  Zi-min Sun,et al.  [Effects of HMGB1 on human cord blood CD34(+) hematopoietic stem cells proliferation and differentiation in vitro.]. , 2010, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[27]  O. Lindvall,et al.  Stem cells in human neurodegenerative disorders--time for clinical translation? , 2010, The Journal of clinical investigation.

[28]  M. Cohen,et al.  Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion , 2009, Critical care.

[29]  Michiyasu Suzuki,et al.  High-Mobility Group Box 1 Protein in CSF of Patients with Subarachnoid Hemorrhage , 2009, Neurocritical care.

[30]  G. Comi,et al.  Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. , 2009, Brain : a journal of neurology.

[31]  L. Wechsler.  Clinical trials of stroke therapy: which cells, which patients? , 2009, Stroke.

[32]  Y. Izci,et al.  Neuroprotective Effects of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells in Transient Focal Cerebral Ischemia in Rats , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  B. Reynolds.  Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke , 2009, Stroke.

[34]  G. Sauvageau,et al.  A Functional Screen to Identify Novel Effectors of Hematopoietic Stem Cell Activity , 2008, Cell.

[35]  K. Tracey,et al.  The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage , 2008, The Journal of Neuroscience.

[36]  Lisheng Wang,et al.  High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway. , 2008, Stem cells and development.

[37]  M. Moskowitz,et al.  Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  Jung‐Bin Kim,et al.  Induction and subcellular localization of high‐mobility group box–1 (HMGB1) in the postischemic rat brain , 2008, Journal of neuroscience research.

[39]  E. Lo.  Experimental models, neurovascular mechanisms and translational issues in stroke research , 2008, British journal of pharmacology.

[40]  Seung-Up Kim,et al.  Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. , 2008, Brain : a journal of neurology.

[41]  M. Hazekawa,et al.  Delayed Treatment With Minocycline Ameliorates Neurologic Impairment Through Activated Microglia Expressing a High-Mobility Group Box1–Inhibiting Mechanism , 2008, Stroke.

[42]  K. Houkin,et al.  Therapeutic Benefits by Human Mesenchymal Stem Cells (hMSCs) and Ang-1 Gene-Modified hMSCs after Cerebral Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  Cheng-Hsien Lu,et al.  Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke , 2008, Stroke.

[44]  T. Yoshino,et al.  Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  M. Bianchi,et al.  Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation , 2007, The Journal of cell biology.

[46]  J. Kalbfleisch,et al.  Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion , 2007, Journal of Neuroimmunology.

[47]  M. Mattson,et al.  Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.

[48]  O. Hurtado,et al.  Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke , 2007, Circulation.

[49]  E. Chavakis,et al.  High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells , 2007, Circulation research.

[50]  Raphael Guzman,et al.  Cell Transplantation Therapy for Stroke , 2007, Stroke.

[51]  M. Chopp,et al.  Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke , 2007, Stroke.

[52]  M. Bianchi,et al.  The secretion of HMGB1 is required for the migration of maturing dendritic cells , 2007, Journal of leukocyte biology.

[53]  M. Capogrossi,et al.  Pivotal Advances: High‐mobility group box 1 protein—a cytokine with a role in cardiac repair , 2007, Journal of leukocyte biology.

[54]  B. Mishra,et al.  Expression and distribution of Toll‐like receptors in the brain during murine neurocysticercosis , 2006, Journal of Neuroimmunology.

[55]  Jong-sang Park,et al.  HMGB1, a Novel Cytokine-Like Mediator Linking Acute Neuronal Death and Delayed Neuroinflammation in the Postischemic Brain , 2006, The Journal of Neuroscience.

[56]  S. Müller,et al.  Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation , 2005, Circulation research.

[57]  Giovanna Angelini,et al.  NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. , 2005, Blood.

[58]  K. Tracey,et al.  The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.

[59]  Ross Zafonte,et al.  Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. , 2005, Journal of neurosurgery.

[60]  M. Norenberg,et al.  Astrocytes in cerebral ischemic injury: Morphological and general considerations , 2005, Glia.

[61]  Oh Young Bang,et al.  Autologous mesenchymal stem cell transplantation in stroke patients , 2005, Annals of neurology.

[62]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[63]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[64]  M. Bianchi,et al.  High mobility group box 1 protein, a cue for stem cell recruitment. , 2004, Biochemical pharmacology.

[65]  H. Naritomi,et al.  Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. , 2004, The Journal of clinical investigation.

[66]  H. Huttunen,et al.  Amphoterin as an extracellular regulator of cell motility: from discovery to disease , 2004, Journal of internal medicine.

[67]  M. Bianchi,et al.  Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.

[68]  Jerry Silver,et al.  Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.

[69]  Osamu Honmo.  [A stem cell therapy for stroke]. , 2003, Rinsho shinkeigaku = Clinical neurology.

[70]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[71]  J. Palmblad,et al.  High mobility group 1 B‐box mediates activation of human endothelium , 2003, Journal of internal medicine.

[72]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[73]  R. Landmann,et al.  Cooperation between toll‐like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram‐negative and gram‐positive bacteria , 2003, European journal of immunology.

[74]  R. Swanson,et al.  Astrocytes and Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[75]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation* , 2002, The Journal of Biological Chemistry.

[76]  A. Ridley,et al.  Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.

[77]  D. Kondziolka,et al.  Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. , 2002, The American journal of pathology.

[78]  A. Buchan,et al.  Transplantation of cultured human neuronal cells for patients with stroke , 2001, Neurology.

[79]  S. Higashiyama,et al.  Regulation of Neuregulin Expression in the Injured Rat Brain and Cultured Astrocytes , 2001, The Journal of Neuroscience.

[80]  H. Huttunen,et al.  Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation* , 2000, The Journal of Biological Chemistry.

[81]  F. Gage,et al.  Regenerating the damaged central nervous system , 2000, Nature.

[82]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[83]  D. Kondziolka,et al.  Transplantation of cultured human neuronal cells for patients with stroke , 2000, Neurology.

[84]  Michael Carey,et al.  Mechanism for Specificity by HMG-1 in Enhanceosome Assembly , 2000, Molecular and Cellular Biology.

[85]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[86]  D. Shapiro,et al.  HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. , 1999, Molecular endocrinology.

[87]  E. Melloni,et al.  Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation , 1997, Neuroscience.

[88]  J. Wrathall,et al.  Neurotrophic factors in central nervous system trauma. , 1995, Journal of neurotrauma.

[89]  B. Volk,et al.  Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum , 1994, Neuroscience Letters.

[90]  D. Edwards,et al.  Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[91]  V. Allfrey,et al.  Estradiol enhanced acetylation of nuclear high mobility group proteins of the uterus of newborn guinea pigs. , 1989, Biochemical and biophysical research communications.

[92]  D. B. Tower,et al.  THE ACTIVITIES OF BUTYRYLCHOLINESTERASE AND CARBONIC ANHYDRASE, THE RATE OF ANAEROBIC GLYCOLYSTS, AND THE QUESTION OF A CONSTANT DENSITY OF GLIAL CELLS IN CEREBRAL CORTICES OF VARIOUS MAMMALIAN SPECIES FROM MOUSE TO WHALE , 1973, Journal of neurochemistry.

[93]  Eng H. Lo,et al.  The Science of Stroke: Mechanisms in Search of Treatments , 2010, Neuron.

[94]  C. Ballard,et al.  Endogenous neurogenesis in the human brain following cerebral infarction. , 2007, Regenerative medicine.

[95]  F. Claessens,et al.  Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. , 2002, The Biochemical journal.

[96]  S. Kumar,et al.  Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. , 1993, Patologia polska.